Status | Study |
Completed |
Study Name: Attentional Bias in Body Dysmorphic Disorder Condition: Body Dysmorphic Disorders Date: 2011-07-15 |
Completed |
Study Name: Escitalopram Neuroimaging Supplement Condition: Body Dysmorphic Disorder Date: 2011-07-15 Interventions: Procedure: PET scan and MRI scan PET: The PET Scan is manu |
Terminated |
Study Name: Study of Patients With Body Image Issues Treated With 2 Different Behavioral Interventions Condition: Body Dysmorphic Disorders Date: 2011-03-07 Interventions: Behavioral: Crooked Mirror Externalization Therapy |
Recruiting |
Study Name: White Light Scanning to Aid Body Contouring: A Pilot Project Condition: Lipodystrophy Body Dysmorphic Disorders Date: 2010-03-09 |
Active, not recruiting |
Study Name: Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals Condition: Obsessive Compulsive Disorder Body Dysmorphic Disorder Date: 2010-02-22 Interventions: Behavioral: Cognitive behavioral therapy (CBT) The participant will then undergo a structured clinical i |
Completed |
Study Name: An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder Condition: Bulimia Nervosa Body Dysmorphic Disorder Date: 2009-12-21 Interventions: Drug: Memantine Drug: Memantine, 10-40 mg daily Othe |
Completed |
Study Name: Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder Condition: Body Dysmorphic Disorder Date: 2009-10-26 Interventions: Behavioral: Cognitive-Behavioral Therapy 20 sessions of Cognitive-Behavioral Therapy |
Completed |
Study Name: Cognitive Behaviour Therapy (CBT) for Body Dysmorphic Disorder (BDD) Condition: Body Dysmorphic Disorder Date: 2009-03-27 Interventions: Behavioral: CBT specific for BDD |
Recruiting |
Study Name: D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder Condition: Body Dysmorphic Disorder Date: 2009-02-10 Interventions: Drug: d-cycloserine 100mg of d |
Completed |
Study Name: Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder Condition: Body Dysmorphic Disorder Date: 2005-12-12 Interventions: Drug: Levetiracetam The initial levetiracetam dose will be 250 mg/day, which will be increased to 250 mg |